VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar TruffelPig (< 20) Submitted: 8/17/2012 11:15:12 PM : Underperform Start Price: $21.82 VVUS Score: +1.23

Citron research.

Featured Broker Partners


Advertisement